Laboratory Assessment of Pilairo Q CPAP Mask Performance and Ease of Use.

NCT ID: NCT02121912

Last Updated: 2019-06-24

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-06-30

Study Completion Date

2016-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Participants will undergo a normal sleep study. They will be randomised to use either a FPH Pilairo Q nasal pillow CPAP mask, or another mask. The sleep technician will record leak and pressure data, and complete questionnaires regarding satisfaction and ease of use at the end of the night. It is hypothesised that the Pilairo Q mask will be superior to other standard masks for CPAP therapy in terms of ease of use, satisfaction and overall titration experience.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will be recruited from patients who visit the sleep lab for CPAP titration. Only eligible participants, that provide written informed consent, will be enrolled into the investigation

Only those participants whom are previously diagnosed with an AHI \>5 can be approached and enrolled into the study.

Once the consent form has been signed, participants will be randomly assigned to receive either Pilairo or any other standard care nasal/nasal pillows mask for their CPAP titration. A randomisation log will be provided by FPH.

The titration session will take place as per the lab's routine practice.

Throughout the night the Sleep Technician will record in the CRF the absolute leak value for the mask every 10 minutes.

At the end of the session the Sleep Technician will complete a questionnaire in relation to the titration experience for that participant/mask. The data will be collected in the CRF that FPH staff will provide to the site.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obstructive Sleep Apnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FPH Pilairo Q CPAP mask

The Sleep Technician will fit the FPH Pilairo Q CPAP mask to the participant.

Group Type EXPERIMENTAL

FPH Pilairo Q CPAP mask

Intervention Type DEVICE

CPAP nasal-pillow mask

Any other market released nasal or nasal-pillow CPAP mask

The Sleep Technologist will fit the participant with any market released nasal or nasal-pillow CPAP mask

Group Type ACTIVE_COMPARATOR

Any other market released nasal or nasal-pillow CPAP mask

Intervention Type DEVICE

Any other market released nasal or nasal-pillow CPAP mask

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

FPH Pilairo Q CPAP mask

CPAP nasal-pillow mask

Intervention Type DEVICE

Any other market released nasal or nasal-pillow CPAP mask

Any other market released nasal or nasal-pillow CPAP mask

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

FPH Pilairo CPAP mask Pilairo Q Pilairo

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* AHI equal or greater than 15 from the diagnostic night.
* Equal or greater than 18 years of age

Exclusion Criteria

* Inability to give informed consent.
* History of intolerance to CPAP.
* Anatomical or physiological conditions making CPAP therapy appropriate (for example a deviated septum)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fisher and Paykel Healthcare

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Martina Neddermann, Dr.med

Role: PRINCIPAL_INVESTIGATOR

Evangelisches Krankenhaus Herne

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Evangelisches Krankenhaus Herne

Herne, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CIA-89

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CPAP In-home Assessment NZ
NCT02804919 COMPLETED NA